Tag: Roche

Top pharma players place their stakes on Chinese market

china street
Pharmaceutical giant Bayer reported a robust growth in its pharmaceutical business in China, as its total sales stood at 17 billion yuan ($2.67 billion) in 2017, a year-on-year growth of 18.3 percent.

Tbilisi held a conference dedicated to cancer immunotherapy

Tbilisi held a Scientific Conference “Cancer Immunotherapy – New Paradigm in Cancer Treatment”. The conference was organized by Roche and connected to the introduction of the immunotherapy drug onto the Georgian market.

Roche Georgia holds a scientific conference in Tbilisi

The conference was organized under the aegis of the pharmaceutical company Roche Georgia and is connected to the introduction of the innovative drug Ocrevus (Ocrelizumab) onto the Georgian pharmaceutical market.

Roche acquires cancer software startup Flatiron Health

The world’s largest biotech company Roche and Flatiron Health, Inc. announced that the two partners have signed a definitive agreement under which Roche will acquire all shares of Flatiron Health.

Pieris Pharmaceuticals entered research collaboration with Roche

Pieris Pharmaceuticals, Inc., a biotechnology company advancing novel bio therapeutics, entered into a research collaboration and license agreement with Roche in cancer immunotherapy

European Commission approved Roche’s Ocrevus

Roche announced today that the European Commission (EC) has granted marketing authorisation for OCREVUS® (ocrelizumab) for patients with multiple sclerosis

Roche and Syapse will cooperate in the field of precision medicine

clinical trials
Syapse, a leading precision medicine company, announced it has entered into a multi-year strategic collaboration with Roche

MacroGenics and Roche will jointly develop a new medicine

MacroGenics announced that it had entered into a research collaboration and license agreement with F. Hoffmann-La Roche

Roche acquires Ignyta company

Roche and Ignyta, Inc. today announced they have entered into a definitive merger agreement for Roche to fully acquire Ignyta

Boehringer Ingelheim announced a collaborative agreement with Roche

Boehringer Ingelheim announced an agreement with Roche, focusing on the discovery and development of novel Locked Nucleic Acid oligonucleotides

Arvinas and Genentech to develop new therapeutics

Arvinas LLC announced it has expanded its ongoing license agreement with Genentech

Russia registers OCREVUS for treatment of multiple sclerosis

An official press conference was held to mark the registration of OCREVUS® (ocrelizumab) in Russia

EMA gave approval to Roche’s multiple sclerosis drug

The European Medicines Agency has recommended granting a marketing authorisation for Ocrevus for the treatment of patients with relapsing multiple sclerosis

Warp Drive Bio and Roche will jointly develop new classes of antibiotics

Warp Drive Bio, Inc., a drug discovery company, announced today that it has formed a strategic collaboration with Roche

Recipharm will manufacture solid dose products for Roche

Recipharm announced that it has entered into collaboration with Roche and signed a long-term manufacturing agreement whereby Recipharm will manufacture a range of solid dose products.

Roche will localize the manufacturing of Gazyva at the facilities of Pharmstandard

Roche and Pharmstandard announced the signing of Supply and Manufacturing Contract and License Agreement aimed at providing the full-cycle localization of Gazyva